{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:35:21Z","timestamp":1791250521602,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s12098-008-0243-y","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T10:01:50Z","timestamp":1233655310000},"page":"1231-1235","source":"Crossref","is-referenced-by-count":22,"title":["Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura"],"prefix":"10.1007","volume":"75","author":[{"given":"Elham","family":"Shahgholi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh","family":"Vosough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kambiz","family":"Sotoudeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadijeh","family":"Arjomandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahla","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Faranoush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Ehsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,4]]},"reference":[{"key":"243_CR1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJM195112202452506","volume":"245","author":"W. Newton","year":"1951","unstructured":"Newton W, Zuelzer WW. Idiopathic thrombocytopenic purpura in childhood. N Eng J Med 1951; 245: 978\u2013985","journal-title":"N Eng J Med"},{"key":"243_CR2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","volume":"364","author":"D.B. Cines","year":"2002","unstructured":"Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Eng J Med 2002; 364: 995\u20131008","journal-title":"N Eng J Med"},{"key":"243_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","volume":"88","author":"J.N. George","year":"1996","unstructured":"George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3\u201340","journal-title":"Blood"},{"key":"243_CR4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","volume":"120","author":"British Society for Haematology.","year":"2003","unstructured":"British Society for Haematology. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574\u2013596","journal-title":"Br J Haematol"},{"key":"243_CR5","first-page":"420","volume":"85","author":"D. Mattia De","year":"2000","unstructured":"De Mattia D, Del Principe D, Del Vecchio GC, Jankovic M, Arrighini A, Giordano P et al. Acute childhood Idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Haematologica 2000; 85: 420\u2013424.","journal-title":"Haematologica"},{"key":"243_CR6","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood.V77.9.1884.1884","volume":"77","author":"J.B. Bussel","year":"1991","unstructured":"Bussel JB, Graziano JN, Kimberly RP, Pahwa S, Aledort LM. Intravenous Anti-D treatment of Immune thrombocytopenic purpura: Analysis of Efficacy, Toxicity, and Mechanism of Effect. Blood 1991; 77: 1884\u20131893.","journal-title":"Blood"},{"key":"243_CR7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0955-3886(98)00042-3","volume":"19","author":"V.S. Blanchette","year":"1998","unstructured":"Blanchette VS, Carcao M. Intravenous Immunoglobulin G and Anti-D as therapeutic interventions in immune thrombocytopenic purpura. Transfusion Science 1998; 19: 279\u2013288.","journal-title":"Transfusion Science"},{"key":"243_CR8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3476(05)80400-7","volume":"123","author":"V.S. Blanchette","year":"1993","unstructured":"Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B et al. A prospective, randomized trial of high- dose intravenous immune globulin G therapy, oral prednisone therapy and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993; 123: 989\u2013995.","journal-title":"J Pediatr"},{"key":"243_CR9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(94)92205-5","volume":"344","author":"V. Blanchette","year":"1994","unstructured":"Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 344: 703\u2013707.","journal-title":"Lancet"},{"key":"243_CR10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00043426-199705000-00004","volume":"19","author":"I. Warrier","year":"1997","unstructured":"Warrier I, Bussel JB, Valdez L, Barbosa J, Beardsley DS. Safety and Efficacy of low dose intravenous Immune Globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. J Pediatr Hematol Oncol 1997; 19: 197\u2013201.","journal-title":"J Pediatr Hematol Oncol"},{"key":"243_CR11","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V89.8.2689","volume":"89","author":"A. Scaradavou","year":"1997","unstructured":"Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM et al. Intravenous anti- D treatment of Immune thrombocytopenic purpura: Experience in 272 patients. Blood 1997; 89: 2689\u20132700.","journal-title":"Blood"},{"key":"243_CR12","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1365-2141.2001.02627.x","volume":"112","author":"G.C. Newman","year":"2001","unstructured":"Newman GC, Novoa MV, Fodero EM, Lesser ML, Woloski BM, Bussel JB. A dose of 75 microg\/kg\/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg\/kg\/d in adults with immune thrombocytopenic purpura. Br J Haematol 2001; 112: 1076\u20131078.","journal-title":"Br J Haematol"},{"key":"243_CR13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00043426-200302000-00009","volume":"25","author":"S.K. Vesely","year":"2003","unstructured":"Vesely SK, Buchanan GR, Adix L, George JN, Cohen AR, Blanchette VS et al. Self reported initial management of childhood idiopathic thrombocytopenic purpura: Results of a survey of members of the American Society of Pediatric Hematology\/Oncology, 2001. J Pediatr Hematol Oncol 2003; 25: 130\u2013134.","journal-title":"J Pediatr Hematol Oncol"},{"key":"243_CR14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00043426-200310000-00011","volume":"25","author":"M. Benesch","year":"2003","unstructured":"Benesch M, Kerbl R, Lackner H, Berghold A, Schwinger W, Triebl-Roth K et al. Low dose versus high- dose Immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: Results of a prospective, randomized single center study. J Pediatr Hematol Oncol 2003; 25: 797\u2013800.","journal-title":"J Pediatr Hematol Oncol"},{"key":"243_CR15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jpeds.2005.11.019","volume":"148","author":"M.D. Tarantino","year":"2006","unstructured":"Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R et al. Single dose of anti-D Immune globulin 75 \u03bcg\/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. J Pediatr 2006; 148: 489\u2013494.","journal-title":"J Pediatr"},{"key":"243_CR16","unstructured":"Intravenous Immunoglobulin: prevention and treatment of disease. NIH consensus development conference statement, 8, no 5, May 21\u201323 1990. Bethesda, MD, USA. Office of medical applications of research. National Institutes of Health 1990."},{"key":"243_CR17","first-page":"112A","volume":"68","author":"R.J. Kurlander","year":"1986","unstructured":"Kurlander RJ, Rosse WF: Efficacy of a 2-day schedule for administering intravenous immunoglobulin in treating adults with ITP. Blood 1986; 68: 112A.","journal-title":"Blood"},{"key":"243_CR18","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V82.5.1415.bloodjournal8251415","volume":"82","author":"B. Godeau","year":"1993","unstructured":"Godeau B, Lesage S, Divine M, Wirquin V, Farcet JP, Bierling P. Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high dose intravenous immunoglobulin. Blood 1993; 82: 1415\u20131421.","journal-title":"Blood"},{"key":"243_CR19","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2141.1999.01766.x","volume":"107","author":"B. Godeau","year":"1999","unstructured":"Godeau B, Caulier MT, Decuypere L, Rose C, Schaeffer A, Bierling P. Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1g\/kg. Br J Haematol 1999; 107: 716\u2013719.","journal-title":"Br J Haematol"},{"key":"243_CR20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0042-9007.2004.00391.x","volume":"86","author":"P. Bierling","year":"2004","unstructured":"Bierling P, Godeau B. Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on. Vox Sanguinis 2004; 86: 8\u201314.","journal-title":"Vox Sanguinis"},{"key":"243_CR21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00062752-200111000-00017","volume":"8","author":"S. Sandler","year":"2001","unstructured":"Sandler S, Gerald MD. Intravenous Rh Immune globulin for treating immune thrombocytopenic purpura. Current Opinion in Hematology 2001; 8: 417\u2013420.","journal-title":"Current Opinion in Hematology"},{"key":"243_CR22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00043426-199707000-00110","volume":"19","author":"R.M. Madden","year":"1997","unstructured":"Madden RM, Smith CM, Scott JP, Bertolone SJ, Sommers N, Arentz L, Tarantino MD. Anti-D immunoglobulin in the initial treatment of acute immune thrombocytopenic purpura in children. J Pediatr Hematol Oncol 1997; 19: 390\u2013391.","journal-title":"J Pediatr Hematol Oncol"},{"key":"243_CR23","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood.V95.8.2523","volume":"95","author":"A.R. Gaines","year":"2000","unstructured":"Gaines AR. Acute onset hemoglobinemia and\/or hemoglobinuria and sequelae following Rho (D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 2000; 95: 2523\u20132529.","journal-title":"Blood"},{"key":"243_CR24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ajh.20295","volume":"78","author":"M. Kumar","year":"2005","unstructured":"Kumar M, Vik TA, Johnson CS, Southwood ME, Croop JM. Treatment outcome and cost of care in children with idiopathic thrombocytopenic purpura. American J Hematology 2005; 78: 181\u2013187.","journal-title":"American J Hematology"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-008-0243-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-008-0243-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-008-0243-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T08:41:13Z","timestamp":1589532073000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-008-0243-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1007\/s12098-008-0243-y","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}